Nigel Brooks

Development Director at CELLCENTRIC LIMITED - Uttlesford, , UK

Nigel Brooks's Colleagues at CELLCENTRIC LIMITED
Neil Pegg

Research & Operations Director, Board Member

Contact Neil Pegg

Stephen Wade

Senior Manufacturing Engineer

Contact Stephen Wade

Karen Clegg

Clinical Operations Director

Contact Karen Clegg

Nigel Brooks's Contact Details
HQ
N/A
Location
Stockport, England, United Kingdom
Company
CELLCENTRIC LIMITED
Nigel Brooks's Company Details
CELLCENTRIC LIMITED logo, CELLCENTRIC LIMITED contact details

CELLCENTRIC LIMITED

Uttlesford, , UK • 20 - 49 Employees
BioTech/Drugs

Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally.p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers.CellCentric's pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise have few alternatives.

N/A
Details about CELLCENTRIC LIMITED
Frequently Asked Questions about Nigel Brooks
Nigel Brooks currently works for CELLCENTRIC LIMITED.
Nigel Brooks's role at CELLCENTRIC LIMITED is Development Director.
Nigel Brooks's email address is ***@cellcentric.com. To view Nigel Brooks's full email address, please signup to ConnectPlex.
Nigel Brooks works in the BioTech/Drugs industry.
Nigel Brooks's colleagues at CELLCENTRIC LIMITED are Neil Pegg, Stephen Wade, Piers Morgan, Jessica Salter, Karen Clegg and others.
Nigel Brooks's phone number is N/A
See more information about Nigel Brooks